about
A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectumEndoplasmic reticulum quality control in cancer: Friend or foe.A recellularized human colon model identifies cancer driver genes.Feeding Angptl4-/- mice trans fat promotes foam cell formation in mesenteric lymph nodes without leading to ascites.Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBHER-associated degradation in health and disease - from substrate to organism
P50
description
investigador
@es
researcher
@en
name
Asmita Bhattacharya
@en
type
label
Asmita Bhattacharya
@en
prefLabel
Asmita Bhattacharya
@en
P31
P496
0000-0002-5669-8036